Close Menu

NEW YORK (360Dx) – Bio-Rad Laboratories said Thursday that the US Food and Drug Administration has cleared its BioPlex 2200 ToRC IgM Assay, an automated and multiplexed panel for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus (CMV).

Toxoplasma gondii, rubella, and CMV are pathogens commonly associated with congenital diseases and therefore are tested during the first trimester of pregnancy.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.